RopesTalk

Join Ropes & Gray’s life sciences and health care attorneys on a four-part podcast series exploring regulatory, compliance and enforcement changes emanating from Washington, D.C. and the potential impact on life sciences companies in 2023. This third episode will focus on what we except to see in the courts throughout 2023. Topics discussed include litigation challenges against the agencies, enforcement litigation by the government and other matters.

Join Ropes & Gray’s life sciences and health care attorneys on a four-part podcast series exploring regulatory, compliance and enforcement changes emanating from Washington, D.C. and the potential impact on life sciences companies in 2023. This second episode will focus on anticipated policy developments from FDA and CMS in 2023. Topics discussed include rulemaking implications of the Food and Drug Omnibus Reform Act (FDORA), accelerated approval reform, potential digital health device and cybersecurity guidance, the end of the public health emergency, the Inflation Reduction Act, Part D reforms, and CMMI and HRSA action around the 340B program.

In this Ropes & Gray podcast, asset management partners Nicole Krea and Joel Wattenbarger discuss three recent headline items in regulatory compliance for private funds: first, the new marketing rule FAQ, with respect to extracted performance; second, the recently released Regulatory Flex Agenda; and, third, the SEC's 2023 exam priorities. The Private Fund Regulatory Update is a series of podcasts discussing key issues of interest and updates in the regulatory and compliance space, focusing in particular on private fund managers.

Join Ropes & Gray’s life sciences and health care attorneys on a four-part podcast series exploring regulatory, compliance and enforcement changes emanating from Washington, D.C. and the potential impact on life sciences companies in 2023. This first episode will focus on key developments from 2022 that we expect to continue to be significant in 2023. Topics discussed include the Inflation Reduction Act, the Food and Drug Omnibus Reform Act (FDORA), possible legislative action related to orphan drug exclusivity, and the full resumption of domestic and international FDA inspections. 

In this episode of There Has to Be a Better Way?, co-hosts Zach Coseglia and Hui Chen interview their colleague at R&G Insights Lab, Dr. Caitlin Handron, about cultural psychology, her field of study. She discusses how cultural factors influence human behavior and how integrating insights from the social sciences can help companies tackle organizational challenges—from compliance programs to diversity, equity and inclusion—in more effective ways.

Over the past few decades, the ITC has become increasingly focused on intellectual property—and specifically patent—disputes between domestic companies. According to some legislators and commentators, this shift has led the application of Section 337 astray from its original intent: adjudicating unfair trade practices in the importation of goods from foreign countries. Thus, over the past decade, there have been a number of proposed tweaks to Section 337, or the ITC more generally, to address issues like alleged non-practicing entity abuse of the ITC or alleged unfair trade practices implemented by China, such as forced technology transfer. In this episode of Talkin’ Trade, Ropes & Gray IP litigators Matt Rizzolo, Matt Shapiro, Brendan McLaughlin, and Nancy Attalla discuss some of the recent proposals and how they would change Section 337 practice. 

Welcome back to There Has to Be a Better Way?, a new podcast series from R&G Insights Lab. In part two of our inaugural episode, Insights Lab founder Zach Coseglia interviews co-host and senior advisor at the Insights Lab Hui Chen about her varied career and why she believes that having a data-driven measurement mindset is a better way to assess compliance programs.

In this Ropes & Gray podcast, asset management partners Isabel Dische, Vince Ip and Chune Loong Lum discuss how both GPs and LPs are thinking about the GP-LP relationship in light of the current choppy fundraising climate and broader global macro trends. How can GPs lure committed LP capital while preserving flexibility for their longer-term success? How can LPs ensure GPs deploy their capital with appropriate discipline? What are the most meaningful “asks” an LP may want to make as it negotiates new fund commitments?

Tune in to the first episode of Ropes & Gray's new podcast series, The Data Day, brought to you by the firm’s data, privacy & cybersecurity practice. This series will focus on the day-to-day effects that data has on all of our lives as well as other exciting and interesting legal and regulatory developments in the world of data, and will feature a range of guests, including clients, regulators and colleagues. This edition celebrates World Data Protection Day, which took place on January 28, by answering questions submitted by our clients and contacts about the landscape of the data, privacy and cybersecurity field of law. Join your hosts Fran Faircloth, a partner in Ropes & Gray's data, privacy & cybersecurity practice based in Washington, D.C., and Edward Machin, a London-based associate in the same group, as they explore topics including the proposed adequacy decision for EU-U.S. data transfers, the likelihood of a U.S. federal privacy law, ransomware demands and other strange and interesting privacy trends as we look ahead into 2023.